Ethical Issue: In Support OF “Legalization Of Drugs”

Ethical Issues in support of the legalization of Drugs

Ethical Issues in support of the legalization of drugs

The use of the drug in medicine has remained an ancient practice. In the United States, ‘Medical Marijuana’ is also consumed in more than twenty states for numerous health reason. Some primary healthcare problems which involve the use the medical marijuana include stress disorders, post-traumatic stress and chemotherapy etc. it is also believed that the users of medical marijuana will increase, as increasing number of patients believe that they feel health disorders with excess use of traditional medicines. Wilkinson and D’Souza believe that there exist ethical problems with the use of drugs, as many American still believe the dependency on drugs as unethical ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"qw0yNqng","properties":{"formattedCitation":"(Wilkinson and D\\uc0\\u8217{}Souza 2014)","plainCitation":"(Wilkinson and D’Souza 2014)","noteIndex":0},"citationItems":[{"id":624,"uris":["http://zotero.org/users/local/pCT5fGyt/items/D37EE46M"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/D37EE46M"],"itemData":{"id":624,"type":"article-journal","title":"Problems with the medicalization of marijuana","container-title":"Jama","page":"2377–2378","volume":"311","issue":"23","source":"Google Scholar","author":[{"family":"Wilkinson","given":"Samuel T."},{"family":"D’Souza","given":"Deepak Cyril"}],"issued":{"date-parts":[["2014"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Wilkinson and D’Souza 2014).

Despite the potential benefits and approved positive outcomes of drugs used in medicine, still research on the therapeutic benefits of drugs is considered unethical and controversial ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"Zj5Gsp1d","properties":{"formattedCitation":"(Andreae et al. 2016)","plainCitation":"(Andreae et al. 2016)","noteIndex":0},"citationItems":[{"id":627,"uris":["http://zotero.org/users/local/pCT5fGyt/items/SVLDYMJH"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/SVLDYMJH"],"itemData":{"id":627,"type":"article-journal","title":"An ethical exploration of barriers to research on controlled drugs","container-title":"The American Journal of Bioethics","page":"36–47","volume":"16","issue":"4","source":"Google Scholar","author":[{"family":"Andreae","given":"Michael H."},{"family":"Rhodes","given":"Evelyn"},{"family":"Bourgoise","given":"Tyler"},{"family":"Carter","given":"George M."},{"family":"White","given":"Robert S."},{"family":"Indyk","given":"Debbie"},{"family":"Sacks","given":"Henry"},{"family":"Rhodes","given":"Rosamond"}],"issued":{"date-parts":[["2016"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Andreae et al. 2016). The opponents of this aspect who base their opinion on ethical consideration must consider the potential benefits of its use on the patients of chemotherapy. Their objection is based on the use of heroin and ketamine. Another reason which gains significant attention is the adverse effects on the society which remains a flawed approach since the use of drug in medicine manufacturing is highly monitored and remains controllable. The research on this aspect is just limited to the fear of legal repercussions and tight regulations.

The ethical use of drugs outweighs the benefits when it comes to considering the worst aspects associated with the negativity associated with it. The controversy attached to the use of drugs is attached to its societal use rather, than the biological advantages attached to it. Some also believe that attached that the use of marijuana medicine will trigger the expansion of its use among society ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"M85szF8I","properties":{"formattedCitation":"(Philipsen et al. 2014)","plainCitation":"(Philipsen et al. 2014)","noteIndex":0},"citationItems":[{"id":636,"uris":["http://zotero.org/users/local/pCT5fGyt/items/AWSLUY7S"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/AWSLUY7S"],"itemData":{"id":636,"type":"article-journal","title":"Medical marijuana: a primer on ethics, evidence, and politics","container-title":"The Journal for Nurse Practitioners","page":"633–640","volume":"10","issue":"9","source":"Google Scholar","title-short":"Medical marijuana","author":[{"family":"Philipsen","given":"Nayna"},{"family":"Butler","given":"Robin D."},{"family":"Simon-Waterman","given":"Christie"},{"family":"Artis","given":"Jylla"}],"issued":{"date-parts":[["2014"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Philipsen et al. 2014). However, it remains a proven fact that conflicting reports about the therapeutic advantages of marijuana medicine remain significant. They must not be referred for political weight or for putting forth some time and narrowly driven agendas.

The ethical issues in the use of drugs exist throughout the length and breadth of the US. It has been a stated fact that physicians who believe that ethical consideration remains a stepping stone in making its use widely accepted should present thorough research and practical manifestation just to create a case for ethically considering the use of drugs in medicine ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"yDJgVPsO","properties":{"formattedCitation":"(Monte, Zane, and Heard 2015)","plainCitation":"(Monte, Zane, and Heard 2015)","noteIndex":0},"citationItems":[{"id":639,"uris":["http://zotero.org/users/local/pCT5fGyt/items/SKT9CF94"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/SKT9CF94"],"itemData":{"id":639,"type":"article-journal","title":"The implications of marijuana legalization in Colorado","container-title":"Jama","page":"241–242","volume":"313","issue":"3","source":"Google Scholar","author":[{"family":"Monte","given":"Andrew A."},{"family":"Zane","given":"Richard D."},{"family":"Heard","given":"Kennon J."}],"issued":{"date-parts":[["2015"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Monte, Zane, and Heard 2015). It might not be that much easy to call for wide use of drugs in medicine, however, it may gradually benefit its use and makes the ethical consideration of drugs a norm. The Marijuana policy in Colorado has been the depiction of such frameworks.

It is also not the US, where ethically a small proportion of the physicians are allowed to use this for medical purposes, rather in other neighbouring countries, the situation remains the same. There are therapeutic advantages of using cannabis or marijuana in medicine which should be given consideration ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"UzQFyube","properties":{"formattedCitation":"(Isaac, Saini, and Chaar 2016)","plainCitation":"(Isaac, Saini, and Chaar 2016)","noteIndex":0},"citationItems":[{"id":642,"uris":["http://zotero.org/users/local/pCT5fGyt/items/C98EP6AU"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/C98EP6AU"],"itemData":{"id":642,"type":"article-journal","title":"The role of medicinal cannabis in clinical therapy: Pharmacists' perspectives","container-title":"PloS one","page":"e0155113","volume":"11","issue":"5","source":"Google Scholar","title-short":"The role of medicinal cannabis in clinical therapy","author":[{"family":"Isaac","given":"Sami"},{"family":"Saini","given":"Bandana"},{"family":"Chaar","given":"Betty B."}],"issued":{"date-parts":[["2016"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Isaac, Saini, and Chaar 2016). The role of pharmacists could be expanded which can ensure that the ethical standard of the use must be met. It is how a gradual acceptance of ethical consideration can be created.

Finally, if the Medical companies are allowed a certain ratio of drugs to be used as a medical condition and are properly released a certificate to timely keep a check over them, it can benefit the cause of ethical consideration of drugs in medicine ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"hwE24Y46","properties":{"formattedCitation":"(Sagy et al. 2018)","plainCitation":"(Sagy et al. 2018)","noteIndex":0},"citationItems":[{"id":643,"uris":["http://zotero.org/users/local/pCT5fGyt/items/XT8A6ZAA"],"uri":["http://zotero.org/users/local/pCT5fGyt/items/XT8A6ZAA"],"itemData":{"id":643,"type":"article-journal","title":"Ethical issues in medical cannabis use","container-title":"European journal of internal medicine","page":"20–22","volume":"49","source":"Google Scholar","author":[{"family":"Sagy","given":"Iftach"},{"family":"Peleg-Sagy","given":"Tal"},{"family":"Barski","given":"Leonid"},{"family":"Zeller","given":"Lior"},{"family":"Jotkowitz","given":"Alan"}],"issued":{"date-parts":[["2018"]]}}}],"schema":"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"} (Sagy et al. 2018). There exist researches which widely talks about the ethical use of medicinal marijuana, but since a societal pressure exists, therefore its wide use may take some time. Lastly, one may consider that the legalization of drugs might take time but has the potential to bring revolution in medicine especially in the therapeutic conditions.

References:

ADDIN ZOTERO_BIBL {"uncited":[],"omitted":[],"custom":[]} CSL_BIBLIOGRAPHY Andreae, Michael H. et al. 2016. “An Ethical Exploration of Barriers to Research on Controlled Drugs.” The American Journal of Bioethics 16(4): 36–47.

Isaac, Sami, Bandana Saini, and Betty B. Chaar. 2016. “The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives.” PloS one 11(5): e0155113.

Monte, Andrew A., Richard D. Zane, and Kennon J. Heard. 2015. “The Implications of Marijuana Legalization in Colorado.” Jama 313(3): 241–242.

Philipsen, Nayna, Robin D. Butler, Christie Simon-Waterman, and Jolla Artis. 2014. “Medical Marijuana: A Primer on Ethics, Evidence, and Politics.” The Journal for Nurse Practitioners 10(9): 633–640.

Sagy, Iftach et al. 2018. “Ethical Issues in Medical Cannabis Use.” European journal of internal medicine 49: 20–22.

Wilkinson, Samuel T., and Deepak Cyril D’Souza. 2014. “Problems with the Medicalization of Marijuana.” Jama 311(23): 2377–2378.